5th annual Biotech and Money / Medtech and Money World Congress 2019 | Biotech and Money | 5 February 2019 | etc.venues St Paul's, 200 Aldersgate, St. Pauls, London EC1A 4HD, United Kingdom

The 2018 key statistics
• The 2018 attendance breakdown
• The 2018 agenda at a glance and full speaker list
• What made the 2018 event unique
• The 2018 attending company list
• How to get involved in 2019

2019 Speakers:

Amina Albeyatti
Head of Business Development, MyClinic.com

Sascha Alilovic
Partner, SHS

Roy Amariglio
Vice President, Orbimed

Simon Amies
Partner, Covington & Burling

Madeleine Armstrong
News Editor, Vantage

Steve Atkinson
CEO, Atlantic Therapeutics

Sophie Baratte
CEO, Cellnovo

Assaf Barnea
CEO, Sanara Ventures

Paul Bateman
CEO, Novate Medical

Alexander Belcredi
CEO, PhagoMed

Alessio Beverina
Founder and Managing Partner, Panakès Partners

Hubert Birner
Managing Partner, TVM Capital Life Science

Michael Bloch
Counsel, Allen & Overy

John Bowis
Former MP, MEP and UK Health Minister

Thomas Burt
Partner, Crossover Fund, Sofinnova

Martha Carruthers
Head of Life Sciences, Medopad

Amanda Cashin
Co-Founder, Illumina Accelerator

Supa Chantschool
Senior Healthcare Editorial Analyst, GlobalData

Pierre Chauvineau
VP, Rhythm Management, Boston Scientific

Alain Chevallier
Partner, Life Sciences, Truffle Capital

Katherine Cohen
Venture Partner, Panacea Venture

Sarah Cole
Partner, Takeda Ventures

David Colpman
Non Exec Director, HRA Pharma, Forendo Pharma

Clive Cookson
Science Editor, Financial Times

Mick Cooper
Healthcare & Life Sciences Analyst, Trinity Delta

Laia Crespo
Head of Europe, Sanofi Ventures

Ian Crosbie
CEO, Sequana Medical

Adrian Dawkes
Managing Director, Pharma Ventures

John Dawson
Managing Director, Pharma Ventures

Don Debethizy
Director, Argenx

Fiona De Hemptinne
Venture Partner, UCB Ventures

Olivier Delporte
CEO, Miracor Medical

Emmanuel De Watteville
General Partner and Co-Founder, BlueOcean Ventures

Victor Dillard
CEO, Desktop Genetics

Dimitri Dimitriou
CEO, Immupharma

Helen Disney
Founder, Unblocked

Matthew Dodds
Vice President, Strategic Planning, Livanova

Lord Drayson
CEO, Sensyne Health

Jørgen Dreyer
CEO, Saniona

Rémi Droller
Managing Partner, Kurma Partners

Alan Edwards
Chairman, ESP Technology, ASEP Healthcare and Credent Medical

Lucie Ellis
Managing Editor, In Vivo

Johnston Erwin
VP Corporate Business Development, Eli Lilly

Peter Finan
Partner, Epidarex Capital

Jason Foster
Managing Partner, Health Equity Consulting

Joan Fitzpatrick
CEO, Kite Medical

Miriam Frieden
VP of Search & Evaluation, Novo Nordisk

Andrew Fried
Life Sciences, Global Industry Leader, IBM

Martin Frost
CEO, CMR Surgical

Jochen Gann
Head of Global M&A and Corporate Finance, Boehringer Ingelheim

Juan Garcia
Managing Partner, Bioseed Capital

Theo Godfrey
Senior Associate, CMS

Christian Glennie
Director - Equity Research, Healthcare, Stifel

Hakan Goker
Senior Investment Director, M Ventures

Jonathan Goldstein
Director, Corporate Research and Ventures, Boston Scientific

Shaun Grady
VP Global Business Development, AstraZeneca

Mattias Häggblom
Portfolio Manager - Global Healthcare, Swedbank Robur

Tim Haines
Managing Partner, Abingworth

Conor Hanley
CEO, FIRE1

Mark Hahnel
Associate Founder, Genomes.io

Deborah Harland
Partner, SR One

Zishan Haroon
General Partner, Julz & Co

Frank Hensel
Principal, High-Tech Gründerfonds

Tony Hickson
CBO, CRUK

John Hodgson
Independent Consultant

Asaf Homossany
Managing Director - EMEA, Nasdaq

Thomas Holm Pedersen
CEO, NMD Pharma

Sarah Hanson
Partner, Co-Chair Life Sciences & Healthcare Sector, CMS Cameron McKenna Nabarro Olswang

Guenter Huhle
Head of Johnson & Johnson Innovation, JLABS EMEA

Jackie Hunter
Chief Executive, BenevolentBio

Anthony Joseph
CTO, Unite Genomics

Christoph Kausch
Founding Partner & CEO, MTIP

Sahil Kirpekar
Business Development, Licensing and Commercial Strategy, Otsuka Pharma

Charity Kufaas
Vice President, Strategy & Business Development EMEA, Medtronic

Yiannis Kiachopoulos
CEO, Causaly

Philip Jarvis
Executive Chairman, ESP Technology

Sree Kant
Head of Business Development, Life Biosciences

Sameer Kothari
CEO, Zilico

Lara Koole
Principal, Philips Health Technology Ventures

Dmitry Kuzmin
Managing Partner, 4BIO Capital Partners

Marc Lambrechts
Senior Investment Manager, Capricorn Venture Partners

Kit Latham
CEO, drfocused

Stephan Lensky
CBO / COO, EpimAb Biotherapeutics

Oliver Litzka
Partner, Andera Partners

Hugh Lloyd-jukes
CEO, Oxehealth

Carole Longson
Former Director of NICE and CSO, ABPI

Thomas Lonngren
Former Head of EMA and Senior Advisor, NDA Group

Phil L'huillier
Head of Business Development, Europe, European Innovation Hub, MSD

Catherine Longworth
Reporter, Medtech Insight, Pharma intelligence

Tim Luker
Emerging Technology & Innovation, BD, Eli Lilly

Eric Mangiardi
CEO, Q3 Medical

Sean Marett
CBO & CCO, BioNTech

Manish Marotkar
Head of Business Development, Siemens Healthineers Digital Ecosystem

Giovanni Mariggi
Partner,Medicxi

Robbie Mclaren
Partner, Latham & Watkins

John Milad
CEO, QuantaDT

Søren Møller
Managing Partner, Novo Seeds

Angeli Möller
Head of IT Business Partnering Research, Bayer Business Services

Piers Morgan
CFO, Verona Pharma

Carina Namih
Partner, Episode 1

Savvas Neophytou
Partner & Head of Life Sciences, Deepbridge Capital

Alexis Normand
Head of Embleema Blockchain, Embleema

Daniel O’mahony
Partner, Seroba Life Sciences

Geraldine O’keeffe
Partner, LSP

Natalie Pankova
COO, Project Shivom

Alex Pasteur
Partner, F-Prime Capital Partners

Morag Peberdy
Of Counsel, Covington & Burling

James Peyer
Managing Partner, Apollo Ventures

Martin Pfister
Senior Investment Manager, HTGF

David Pinniger
Fund Manager - Biotechnology, Polar Capital

John Power
CEO & Managing Director, Aerogen Ltd

Pablo Prieto
CTO, Lifebit

Luis Eduardo Hinojosa Puerta
CBO, BioCubaFarma

Aditya Puri
Partner - Investments, Xeraya Capital

Conrad Rasmus
Co-Founder, Protembis

Cécile Real
CEO, EndoDiag

Josh Richardson
Managing Director, Longitude Capital

Elizabeth Roper
Partner, Epidarex Capital

Dan Rose
CEO, Limflow

Christoph Ruedig
Partner, Albion Capital

Josep Sanfeliu
Managing Partner, Asabys Partners

Dominic Schmidt
Partner, Syncona Investment Management

Matthew Scholz
CEO, Oisin Biotechnologies

Pavithra Sundaresan
Senior Director, New Ventures and Transactions, Immunology, Johnson & Johnson Innovation

Graziano Seghezzi
Managing Partner, Sofinnova Partners

Johan Sellström
Co-Founder, CareChain

Melanie Senior
Analyst and Specialist Writer, Life Sciences

Raja Sharif
CEO, FarmaTrust

Nigel Sheail
Global Head of M&A and BD&L, Novartis

David Shields
Head, Centers for Therapeutic Innovation East, Pfizer Worldwide Research & Development

Julie Simmonds
Director Equity Research, Panmure Gordon

Harpreet Singh
CEO, Immatics US

Yochi Slonim
CEO, Anima Biotech

Andy Smith
Director / Analyst, Healthcare, Edison

Patrik Sobocki
Investment Manager, Industrifonden

Lena Söderstrom
Board Member, Genovis, Dicot AB and Bio-Works Technologies

Bobby Soni
Partner - Life Science Investments, IP Group

Nikolaj Sorenson
CEO, Orexo

Ivo Staijen
Portfolio Manager, HBM Partners

Sten Stovall
Senior Editor, Informa Business Intelligence

Johan Strömquist
CEO, NDA Group

Teemu Suna
CEO, Nightingale Health

Casey Swerner
Investor, DN Capital

Ashu Tandon
Chief Commercial Officer, Syngene

Ashu Tandon
Executive Editor, Firstword Medtech

Ben Thorpe
Head of Healthcare Investment Banking EMEA, Goldman Sachs

Kai W. Trompeter
President & CEO, INSIGHTRA MEDICAL

David Tuch
CEO, Lightpoint Medical

Lisa Urquhart
Editor, Vantage

Anton Ussi
Director Operations & Finance, EATRIS

Patrick Van Beneden
Partner, Gimv

Laurent Vandebrouck
CEO, Chronolife and Connected Health Development

Peter Van De Berg
Senior Innovation Consultant, Philips Innovation Services

Bart Van Hooland
Founding Partner, DROIA

Edward Van Wezel
Managing Partner, BioGeneration Ventures

Gary Waanders
Managing Director - UK Healthcare Research, Bryan, Garnier & Co.

Susana Waesch
VP Quality Management & Regulatory Affairs, Ypsomed AG

Elaine Warburton
CEO, QuantumDx

Franz Warner Haas
COO, CureVac

Chris Weatherall
Vice President, RA/QA/QC, Meridian Bioscience

Nathalie Ter Wengel
European Head Worldwide Business Development, Pfizer

Tina Woods
Chair, Future Health Collective

Boris Zaitra
Global Head of M&A, Roche

2019 Sponsors adn Partners:

PLATINUM PARTNERS:
• Goldman Sachs
• Lilly
• Medtronic
• Nasdaq

GOLD PARTNERS:
• Allen & Overy
• Citi
• CMS
• Covington
• Freshfields
• Goodwin
• Illumina
• Latham and WatkinS
• MSD
• SVB Leerink
• Syngene
• White & Case

SILVER PARTNERS:
• Bird & Bird
• Choose New Jersey
• FTI Consulting
• NDA Group

MEDIA PARTNERS:
• Biopartner UK
• BioStock
• FreeMind
• International Pharmaceutical Industry
• Labiotech
• LSE
• Mednous
• Optimum Communications
• PharmiWeb.com
• Sciad